Cargando…
Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial
Osteopontin (OPN) is a secreted glycophosphoprotein that has a role in inflammation, immune response and calcification. We hypothesized that plasma OPN levels are associated with adverse cardiovascular outcomes in patients with stable coronary artery disease (CAD) and preserved ejection fraction (EF...
Autores principales: | Abdalrhim, Ahmed D., Marroush, Tariq S., Austin, Erin E., Gersh, Bernard J., Solak, Nusret, Rizvi, Syed A., Bailey, Kent R., Kullo, Iftikhar J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902195/ https://www.ncbi.nlm.nih.gov/pubmed/27284698 http://dx.doi.org/10.1371/journal.pone.0156965 |
Ejemplares similares
-
Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study
por: Kullo, Iftikhar J., et al.
Publicado: (2018) -
Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023) -
Genotype-informed estimation of risk of coronary heart disease based on genome-wide association data linked to the electronic medical record
por: Ding, Keyue, et al.
Publicado: (2011) -
World Peace in One Hour
Peace is Profitable
Roadmap to Peace
por: Bach, Nenad
Publicado: (2018) -
EHPnet: Peace Child International
por: Dooley, Erin E.
Publicado: (2007)